Year archive

Immunotech Biopharm Ltd — 2021 filings

All 46 regulatory filings released by Immunotech Biopharm Ltd (6978) in 2021, sourced directly from the official regulator.

46 Filings

2021 Period

2021 filings (46)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Regulatory Filings	2021-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Regulatory Filings	2021-11-03	English
DISCLOSEABLE TRANSACTION IN RELATION TO THE LEASE AGREEMENT Regulatory Filings	2021-10-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2021 Regulatory Filings	2021-09-30	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2021 Regulatory Filings	2021-09-30	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2021 Regulatory Filings	2021-09-30	English
2021 INTERIM REPORT Regulatory Filings	2021-09-20	English
VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED Regulatory Filings	2021-09-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Regulatory Filings	2021-09-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2021 Regulatory Filings	2021-09-03	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Regulatory Filings	2021-08-23	English
APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTOR CHANGE OF AUDIT COMMITTEE MEMBER AND APPOINTMENT AND RESIGNATION OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE Regulatory Filings	2021-08-23	English
ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 Regulatory Filings	2021-08-23	English
DATE OF BOARD MEETING Regulatory Filings	2021-08-10	English
VOLUNTARY ANNOUNCEMENT PUBLICATION OF RESEARCH ARTICLE IN RELATION TO 6B11-OCIK Regulatory Filings	2021-08-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2021 Regulatory Filings	2021-08-04	English
VOLUNTARY ANNOUNCEMENT POSSIBLE INCOMING SUBSTANTIAL SHAREHOLDER Regulatory Filings	2021-07-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2021 Regulatory Filings	2021-07-05	English
VOLUNTARY ANNOUNCEMENT COMMENCEMENT OF CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASE IN BEIJING Regulatory Filings	2021-06-17	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL FOR CAR-T-19 INJECTION Regulatory Filings	2021-06-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2021 Regulatory Filings	2021-06-03	English
MAJOR TRANSACTION CONSTRUCTION AGREEMENT IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASE IN BEIJING Regulatory Filings	2021-05-26	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 MAY 2021 Regulatory Filings	2021-05-21	English
MAJOR TRANSACTION FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASED IN BEIJING Regulatory Filings	2021-05-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2021 Regulatory Filings	2021-05-06	English
MAJOR TRANSACTION DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASED IN BEIJING Regulatory Filings	2021-04-22	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2021-04-20	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 21 MAY 2021 Regulatory Filings	2021-04-20	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2021-04-20	English
2020 ANNUAL REPORT Regulatory Filings	2021-04-20	English
CHANGE OF SENIOR MANAGEMENT Regulatory Filings	2021-04-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2021 Regulatory Filings	2021-04-08	English
MAJOR TRANSACTION CONSTRUCTION AGREEMENT IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASE IN BEIJING Regulatory Filings	2021-03-29	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 Regulatory Filings	2021-03-25	English
DATE OF BOARD MEETING Regulatory Filings	2021-03-15	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON PHASE 1 CLINICAL TRIAL OF 6B11-OCIK INJECTION Regulatory Filings	2021-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2021 Regulatory Filings	2021-03-03	English
VOLUNTARY ANNOUNCEMENT UPDATE REGARDING RECENT BUSINESS DEVELOPMENT Regulatory Filings	2021-02-25	English
VOLUNTARY ANNOUNCEMENT ESTABLISHMENT OF AND INVESTMENT IN CELLULAR IMMUNOTHERAPY SPECIALISED INDUSTRY FUND AS A LIMITED PARTNER Regulatory Filings	2021-02-25	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2021 Regulatory Filings	2021-02-04	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION SUBSCRIPTION IN AN INVESTMENT FUND Regulatory Filings	2021-01-13	English
VOLUNTARY ANNOUNCEMENT LOCK-UP UNDERTAKING BY CERTAIN SHAREHOLDERS Regulatory Filings	2021-01-12	English
DISCLOSEABLE TRANSACTION EXCLUSIVE LICENSE AGREEMENT WITH T-CURE Regulatory Filings	2021-01-12	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION SUBSCRIPTION IN AN INVESTMENT FUND Regulatory Filings	2021-01-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2020 Regulatory Filings	2021-01-06	English
DISCLOSEABLE TRANSACTION SUBSCRIPTION IN AN INVESTMENT FUND Regulatory Filings	2021-01-03	English